We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Radcal IBA  Group

Download Mobile App




Electronic Glasses Effective in Amblyopia Treatment

By HospiMedica International staff writers
Posted on 24 Nov 2015
A new study shows that programmable digital glasses for treating amblyopia (lazy eye) work as well as eye patching.

Researchers at Indiana University (Bloomington, IN, USA) conducted a randomized clinical study among 33 children with lazy eye (between three and eight years of age) to test the effectiveness of occlusion glasses, as compared to eye patching. More...
One group of the children wore an adhesive patch for two hours daily; the other wore Amblyz occlusion glasses for four hours daily, with the liquid crystal display (LCD) digital lens over the eye with better vision switched from clear to opaque every 30 seconds.

The results revealed that after three months, both groups of children showed the same amount of improvement in the lazy eye, gaining two lines on a reading chart. According to the researchers, the programmable digital glasses are the first new effective lazy eye treatment in 50 years. The study was presented at the annual meeting of the American Academy of Ophthalmology (AAO), held during November 2015 in Las Vegas (NV, USA).

“When you talk to adults who underwent childhood treatment for amblyopia, they will tell you that wearing a patch was the worst thing ever,” said lead author and study presenter Prof. Daniel Neely, MD, a pediatric ophthalmologist at the Indiana University Glick Eye Institute. “With these electronic occlusion glasses, the child learns that the lens will be clear again in just a few seconds so they may be more cooperative with the treatment. For parents who have struggled with drops and patching, this could be a great alternative.”

Amblyz glasses, a product of Xpand (Ljubljana, Slovenia), are based on an electronic shutter controlled by a preprogrammed microchip incorporated into an optical refractive lens. The liquid crystal shutter is suspended in a gel-like liquid between two thin glass plates coated with a thin polarizer film. When an electric voltage is applied, the spatial orientation of the suspended molecules is changed and the polarity of the light is rotated, applying short intermittent occlusions of the strong eye.

Amblyopia is an eye disorder characterized by an impaired vision in an eye that otherwise appears normal. Visual stimulation either fails to transmit or is poorly transmitted through the optic nerve to the brain for a continuous period of time. It can also occur when the brain "turns off" the visual processing of one eye to prevent double-vision, for example in strabismus. Detecting the condition in early childhood increases the chance of successful treatment, especially if detected before the age of five.

Related Links:

Indiana University
Xpand



Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
New
Warming Cabinet
EC1850BL
New
Multifunctional Patient Floor Lift
Maxi Move 5
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The Minder Implant can record brain activity continuously for very long periods (Photo courtesy of Epiminder)

Implantable Device Continuously Monitors Brain Activity in Epileptic Patients

Epilepsy is one of the most prevalent and serious chronic neurological disorders, impacting around 52 million people globally. It is characterized by recurrent seizures, which are caused by abnormal electrical... Read more

Surgical Techniques

view channel
Image: The engine-free, nonlinear, flexible, micro-robotic platform leverages AI to optimize GBM treatment (Photo courtesy of Symphony Robotics)

First-Ever MRI-Steerable Micro-Robotics to Revolutionize Glioblastoma Treatment

Glioblastoma Multiforme (GBM) is one of the most aggressive and difficult-to-treat brain cancers. Traditional surgical procedures, such as craniotomies, involve significant invasiveness, requiring large... Read more

Patient Care

view channel
Image: The portable biosensor platform uses printed electrochemical sensors for the rapid, selective detection of Staphylococcus aureus (Photo courtesy of AIMPLAS)

Portable Biosensor Platform to Reduce Hospital-Acquired Infections

Approximately 4 million patients in the European Union acquire healthcare-associated infections (HAIs) or nosocomial infections each year, with around 37,000 deaths directly resulting from these infections,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.